Publication | Open Access
Biosynthesis of platelet activating factor in rabbit polymorphonuclear neutrophils.
160
Citations
29
References
1983
Year
ImmunologyPlatelet PathobiologyIonophore A23187Cellular PhysiologyInflammationThrombosisEthanolamine Phosphoglyceride PoolsHematologyBiochemistryGranulocyteVascular BiologyCell BiologyDeacylation-reacylation MechanismThrombopoiesisPlatelet ActivationSignal TransductionRabbit Polymorphonuclear NeutrophilsBlood PlateletEndothelial DysfunctionHemostasisMedicine
The synthesis of platelet activating factor (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) was studied in rabbit peritoneal polymorphonuclear neutrophils. Upon stimulation with ionophore A23187 and Ca2+, these cells are able to incorporate [3H]acetate or 1-O-[3H]alkyl-2-lyso-sn-glycero-3-phosphocholine into platelet activating factor. Under the same incubation conditions, however, the cells do not synthesize platelet activating factor from [14C]hexadecanol, which is an immediate precursor of O-alkyl chains in the de novo pathway. In the absence of ionophore, [14C] hexadecanol is incorporated into 1-O-alkyl-2-acyl-sn-glycerol-3-phosphate and subsequently into the 1-O-alkyl-linked choline and ethanolamine phosphoglyceride pools. However, in the presence of ionophore, [14C] hexadecanol incorporation is limited to phosphatidic acid, perhaps due to the inhibition of choline phosphotransferase. These findings provide strong evidence that platelet activating factor is synthesized by a deacylation-reacylation mechanism. Upon stimulation, these cells can utilize both plausible substrates of this pathway to make the final product, while under the same conditions it appears that a key step of the de novo pathway is inhibited.
| Year | Citations | |
|---|---|---|
Page 1
Page 1